Axcella Health Inc.
Axcella Health Inc. (AXLA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AXLA · as of Jun 9, 2026
Key Statistics
Explore Axcella Health Inc. Data
axla stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 60.0%
The AXLA analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $60.00, representing +1210.04% upside from the current price of $4.58.
Competitors & Peers
axla competitorsAXLA
AMTI
CYAD
GLS
HURA
KRROStock Performance
Full HistoryAbout Axcella Health Inc.
Axcella Health Inc. is a U.S.-based clinical-stage biotechnology firm focused on developing novel therapeutic compositions derived from endogenous metabolic modulators. These aim to address complex di…
what is axcella health inc. · axla stock overview · axcella health inc. company profile · who is axcella health inc. ceo · axla NASDAQ · axcella health inc. headquarters · axcella health inc. business segments
About Stock Overview & Key Data
Axcella Health Inc. (AXLA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 9, 2019. As of the latest trading session, AXLA stock price is $4.58, with a market capitalization of $12.5M. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
According to 10 Wall Street analysts, the consensus rating for Axcella Health Inc. stock is Buy, with an average 12-month price target of $60.00. In fiscal year 2022, Axcella Health Inc. reported revenue of — and net income of -$81.2M. For detailed data — including Axcella Health Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Axcella Health Inc. (AXLA) stock price is $4.58. The stock is traded on NASDAQ under the ticker symbol AXLA. The 52-week range is $4.58 – $4.58.